Exploring new compounds that fight breast cancer
Characterization of novel pyrazole compounds with potent anti-cancer activity
This study is looking at new medicines made from pyrazole to see if they can help treat Triple Negative Breast Cancer, which is a tough type of breast cancer, and aims to find better options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas El Paso NIH-funded |
| Lab location | 1 site (El Paso, United States) |
| Project ID | NIH-11057589 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of novel pyrazole compounds in treating Triple Negative Breast Cancer (TNBC), a particularly aggressive form of breast cancer. The team has screened thousands of compounds to identify those that can effectively kill cancer cells. Using advanced live-cell imaging techniques, they have found several promising candidates that induce cancer cell death through specific biological mechanisms. The goal is to understand how these compounds work and to develop new treatment options for patients with TNBC.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with Triple Negative Breast Cancer who have limited treatment options.
Not a fit: Patients with other types of breast cancer or those who are not diagnosed with cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments for patients suffering from Triple Negative Breast Cancer.
How similar studies have performed: Previous research has shown promise in using novel compounds to target aggressive cancer types, suggesting potential success for this approach.
Where this research is happening
El Paso, United States
- University of Texas El Paso — El Paso, United States (Active)
Researchers
- Principal investigator: Aguilera, Renato J — University of Texas El Paso
- Study coordinator: Aguilera, Renato J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.